| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 258,000 | 185,400 | 333,100 | 365,100 |
| Cost of sales | 141,600 | 109,100 | 199,200 | 227,200 |
| Gross profit | 116,400 | 76,300 | 133,900 | 137,900 |
| Selling, general, and administrative expenses | 40,700 | 39,800 | 44,100 | 44,200 |
| Research and technical expenses | 6,700 | 5,900 | 7,000 | 7,800 |
| Restructuring charges | 500 | -22,400 | 1,000 | NaN |
| Other (income) charges, net | 0 | 0 | 0 | NaN |
| Restructuring and other (income) charges, net | 500 | -22,400 | 1,000 | 21,900 |
| Goodwill impairment charge | NaN | 80,400* | 0 | 183,800 |
| Long lived asset impairment charge | NaN | 27,325* | NaN | NaN |
| Acquisition-related costs | NaN | 0* | 0 | 0 |
| (gain) loss on strategic investments (note 5) | NaN | -14,050* | NaN | NaN |
| Foreign currency transaction (gain)/loss | NaN | 150* | NaN | NaN |
| Ceo severance charges | NaN | 0* | NaN | NaN |
| Portfolio realignment costs | NaN | 775* | NaN | NaN |
| Proxy contest charge | NaN | 2,050* | NaN | NaN |
| Other (income)/expense, net | NaN | 1,325* | NaN | NaN |
| Other (income) expense, net | -22,400 | -15,400 | -1,200 | -4,300 |
| Interest expense | NaN | 19,575* | NaN | NaN |
| Interest income | NaN | 1,300* | NaN | NaN |
| Interest expense, net | -15,900 | NaN | -18,400 | -18,600 |
| Income (loss) from continuing operations before income taxes | 30,200 | -88,400 | 62,200 | -142,700 |
| (provision) benefit for income taxes on continuing operations | 6,800 | -23,300 | 21,400 | 3,800 |
| Net income (loss) from continuing operations | 23,400 | -59,700* | 40,800 | NaN |
| Net sales | 0 | 34,600* | 29,000 | NaN |
| Cost of sales | 0 | 38,700* | 18,000 | NaN |
| Gross profit | 0 | -4,100* | 11,000 | NaN |
| Selling, general, and administrative expenses | 0 | 1,000* | 900 | NaN |
| Research and technical expenses | 0 | 1,000* | 600 | NaN |
| Restructuring and other (income) charges, net | 7,800 | 16,500* | 8,800 | NaN |
| Goodwill impairment charge | NaN | 0* | 0 | NaN |
| (gain) loss on sale of business | 55,600 | NaN | NaN | NaN |
| Other (income) expense, net | 0 | 2,100* | -1,000 | NaN |
| Income (loss) from discontinued operations before income taxes | 47,800 | -24,700* | 1,700 | NaN |
| Provision (benefit) for income taxes on discontinued operations | 11,400 | 200* | -1,000 | NaN |
| Income (loss) from discontinued operations, net of income taxes | 36,400 | -24,900* | 2,700 | NaN |
| Net income (loss) | 59,800 | -84,600 | 43,500 | -146,500 |
| Basic EPS | 1.7 | -2.367 | 1.2 | -4.02 |
| Diluted EPS | 1.66 | -2.43 | 1.18 | -4.02 |
| Basic Average Shares | 35,257,000 | 35,736,000 | 36,309,000 | 36,461,000 |
| Diluted Average Shares | 36,019,000 | 34,809,000 | 36,955,000 | 36,461,000 |
Ingevity Corp (NGVT)
Ingevity Corp (NGVT)